Pfizer (PFE) Other Accumulated Expenses (2009 - 2026)
Pfizer's Other Accumulated Expenses came in at $21.15 billion for Q3 2026, up 8.4% from $19.51 billion a year earlier and up 7.3% from the prior quarter.
Powered by 
Analysis
Pfizer (PFE) Other Accumulated Expenses (2009 - 2026) Analysis & Trends
At the end of FY2025, Pfizer's Other Accumulated Expenses was $19.43 billion, down 1.5% from FY2024.
- Other Accumulated Expenses has declined in each of the last four years, though with a five-year compound annual growth rate of 10.9% (FY2020 to FY2025).
- Going back by year, Other Accumulated Expenses was $19.72 billion in FY2024 (-4.0%), $20.54 billion in FY2023 (-9.0%), $22.57 billion in FY2022 (-9.5%) and $24.94 billion in FY2021 (+115.7%).
- The Q3 2026 figure represents the highest quarterly Other Accumulated Expenses since Q4 2022.
- Year-over-year, Other Accumulated Expenses has increased for three consecutive quarters, with growth averaging 3.4% over the last eight quarters.
- The fastest year-over-year change in Other Accumulated Expenses over five years came in Q4 2021 (growth of 115.7%), and the weakest in Q2 2023 (a decline of 32.5%).
- Business Quant data shows PFE's Other Accumulated Expenses at $19.71 billion (Q2 2026), $20.11 billion (Q1 2026) and $19.43 billion (Q4 2025) in the three quarters before Q3 2026.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Eli Lilly | 1,224.11 Bn | 1,197.72 Bn | 20.46 Bn |
| 2 | Johnson & Johnson | 665.34 Bn | 585.20 Bn | 17.30 Bn |
| 3 | AbbVie | 515.72 Bn | 483.73 Bn | 13.12 Bn |
| 4 | Merck | 362.64 Bn | 325.58 Bn | 13.19 Bn |
| 5 | Novartis Ag | 315.51 Bn | 288.75 Bn | - |
| 6 | Astrazeneca | 289.26 Bn | 263.15 Bn | 13.26 Bn |
| 7 | Amgen | 249.20 Bn | 200.85 Bn | 7.58 Bn |
| 8 | Gilead Sciences | 207.48 Bn | 182.59 Bn | 6.73 Bn |
| 9 | Pfizer | 167.49 Bn | 114.85 Bn | 12.56 Bn |
| 10 | Vertex Pharmaceuticals | 138.73 Bn | 110.72 Bn | 2.91 Bn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Sep 27, 2026 | 21.15 Bn |
| Jun 28, 2026 | 19.71 Bn |
| Mar 29, 2026 | 20.11 Bn |
| Dec 31, 2025 | 19.43 Bn |
| Sep 28, 2025 | 19.51 Bn |
| Jun 29, 2025 | 18.58 Bn |
| Mar 30, 2025 | 20.02 Bn |
| Dec 31, 2024 | 19.72 Bn |
| Sep 29, 2024 | 19.92 Bn |
| Jun 30, 2024 | 16.41 Bn |
| Mar 31, 2024 | 18.79 Bn |
| Dec 31, 2023 | 20.54 Bn |
| Oct 1, 2023 | 16.78 Bn |
| Jul 2, 2023 | 16.08 Bn |
| Apr 2, 2023 | 20.26 Bn |
| Dec 31, 2022 | 22.57 Bn |
| Oct 2, 2022 | 19.65 Bn |
| Jul 3, 2022 | 23.82 Bn |
| Apr 3, 2022 | 24.58 Bn |
| Dec 31, 2021 | 24.94 Bn |
API Access
Pfizer Other Accumulated Expenses API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=other-accumulated-expenses&ticker=PFE&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "other-accumulated-expenses", "ticker": "PFE", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=other-accumulated-expenses&ticker=PFE&period=max&api_key=YOUR_API_KEY");
const data = await res.json();